TD Securities Begins Coverage on Zymeworks (NYSE:ZYME)
Investment analysts at TD Securities started coverage on shares of Zymeworks (NYSE:ZYME – Get Free Report) in a report released on Tuesday,Benzinga reports. The firm set a “buy” rating on the stock. ZYME has been the topic of a number of other reports. HC Wainwright boosted their price objective on shares of Zymeworks from $12.00 […]
